Affiliation:
1. Oral Medicine, Division of Maxillofacial Diagnostic, Medical & Surgical Sciences, Eastman Dental Institute for Oral Health Care Sciences, UCL, University of London, 256 Gray’s Inn Road, London WC1X 8LD, UK;
Abstract
Behçet’s disease (BD) is a multi-system inflammatory disorder dominated clinically by recurrent oral and genital ulceration, uveitis, and erythema nodosum. Behçet’s disease runs a chronic course, with unpredictable exacerbations and remissions whose frequency and severity may diminish with time. Behçet’s disease typically arises in young adults, although childhood-onset BD has also been reported. The disease can affect both genders and has a worldwide distribution, although it is more prevalent in countries of the ancient Silk Route. The cause of BD remains unknown, although an autoimmune reaction triggered by an infectious agent in a genetically predisposed individual has been suggested. The treatment of BD is symptomatic and empirical, but generally specific to the clinical features of each patient. The majority of affected individuals do not have life-threatening disease, although mortality can be associated with vascular-thrombotic and neurological disease.
Reference187 articles.
1. Seven-Year Follow-up of Neurologic Involvement in Behcet Syndrome
2. Akoglu TF, Direskeneli H, Yazici H, Lawrence R (1990). TNF, soluble IL-2R and soluble CD-8 in Behçet’s disease. J Rheumatol 17:1107–1108.
3. Renal Behçet's disease: A cumulative analysis
4. Prevalences of hepatitis A, B, C and E viruses in Behçet's disease
5. Aktulga E, Altac M, Muftuoglu A, Ozyazgan Y, Pazarli H, Tuzun Y, et al. (1980). A double blind study of colchicine in Behçet’s disease. Haematologica 65:399–402.
Cited by
72 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献